Skip to content


Urological oncology

This section considers clinical studies relevant to oncological disorders in urology

Page 4 of 4

  1. Content type: Research article

    Radiotherapy is an increasingly preferred treatment option for localized prostate cancer, and stereotactic body radiation therapy (SBRT) a relatively established modality of therapeutic irradiation. The presen...

    Authors: Giampaolo Bolzicco, Maria Silvia Favretto, Ninfa Satariano, Enrico Scremin, Carmelo Tambone and Andrea Tasca

    Citation: BMC Urology 2013 13:49

    Published on:

  2. Content type: Research article

    Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in...

    Authors: Shingo Hatakeyama, Takahiro Yoneyama, Itsuto Hamano, Hiromi Murasawa, Takuma Narita, Masaaki Oikawa, Kazuhisa Hagiwara, Daisuke Noro, Toshikazu Tanaka, Yoshimi Tanaka, Yasuhiro Hashimoto, Takuya Koie and Chikara Ohyama

    Citation: BMC Urology 2013 13:47

    Published on:

  3. Content type: Research article

    In this study, we further investigated the association of two biomarkers, CCL18 and A1AT, with bladder cancer (BCa) and evaluated the influence of potentially confounding factors in an experimental model.

    Authors: Makito Miyake, Shanti Ross, Adrienne Lawton, Myron Chang, Yunfeng Dai, Lourdes Mengual, Antonio Alcaraz, Evan Gomes Giacoia, Steve Goodison and Charles J Rosser

    Citation: BMC Urology 2013 13:42

    Published on:

  4. Content type: Research article

    Imprinting is an important epigenetic regulator of gene expression that is often disrupted in cancer. While loss of imprinting (LOI) has been reported for two genes in prostate cancer (IGF2 and TFPI2), disease-re...

    Authors: Daniel I Jacobs, Yingying Mao, Alan Fu, William Kevin Kelly and Yong Zhu

    Citation: BMC Urology 2013 13:37

    Published on:

  5. Content type: Case report

    Villous adenoma arising in the urinary tract is rare tumor. Most cases have been identified as benign neoplasm in the colon. Villous adenoma of the gastrointestinal tract is thought arise from premalignant pol...

    Authors: Yoichiro Kato, Susumu Konari, Wataru Obara, Tamotsu Sugai and Tomoaki Fujioka

    Citation: BMC Urology 2013 13:36

    Published on:

  6. Content type: Research article

    To date, elective nephron-sparing surgery is an established method for the exstirpation of renal tumors. While open partial nephrectomy remains the reference standard of the management of renal masses, laparos...

    Authors: Hagen Loertzer, Arne Strauß, Rolf Herrmann Ringert and Philine Schneider

    Citation: BMC Urology 2013 13:31

    Published on:

  7. Content type: Case report

    Renal cell carcinoma (RCC) is a histopathologically and molecularly heterogeneous disease with the chromophobe subtype (chRCC) accounting for approximately 5% of all cases. The median overall survival of advan...

    Authors: Balaji Venugopal, Jawaher Ansari, Michael Aitchison, Lye Mun Tho, Roderick Campbell and Rob J Jones

    Citation: BMC Urology 2013 13:26

    Published on:

  8. Content type: Research article

    Matrix Metalloproteinases (MMPs) are key molecules for tumor growth, invasion and metastasis. Over-expression of different MMPs in tumor tissues can disturb the homeostasis and increase the level of various bo...

    Authors: Mohammed A Mohammed, Manar F Seleim, Mohga S Abdalla, Hayat M Sharada and Abdel Hady A Abdel Wahab

    Citation: BMC Urology 2013 13:25

    Published on:

  9. Content type: Research article

    The management of patients with high-grade non muscle invasive bladder cancer (NMIBC) brings diagnostic and therapeutic challenges. In the current study, we sought to study the natural history of progression t...

    Authors: Guy Hidas, Dov Pode, Amos Shapiro, Ran Katz, Liat Appelbaum, Galina Pizov, Kevin C Zorn, Ezekiel H Landau, Mordechai Duvdevani and Ofer N Gofrit

    Citation: BMC Urology 2013 13:23

    Published on:

  10. Content type: Research article

    Pheochromocytoma (paraganglioma) of the urinary bladder is a rare tumor. Herein we sought to review the contemporary literature on pheochromocytomas of the urinary bladder in order to further illustrate the pr...

    Authors: Jonathan A Beilan, Adrienne Lawton, Julio Hajdenberg and Charles J Rosser

    Citation: BMC Urology 2013 13:22

    Published on:

  11. Content type: Case report

    Malignant transformation describes the phenomenon in which a somatic component of a germ cell teratoma undergoes malignant differentiation. A variety of different types of sarcoma and carcinoma, all non-germ c...

    Authors: Nina Zeh, Peter J Wild, Peter K Bode, Glen Kristiansen, Holger Moch, Tullio Sulser and Thomas Hermanns

    Citation: BMC Urology 2013 13:9

    Published on:

  12. Content type: Research article

    We sought to improve prostate cancer (PC) detection through developing a prostate biopsy clinical decision rule (PBCDR), based on an elevated PSA and laboratory biomarkers. This decision rule could be used aft...

    Authors: Owen T Hill, Thomas J Mason, Skai W Schwartz and Philip R Foulis

    Citation: BMC Urology 2013 13:6

    Published on:

  13. Content type: Research article

    Urinary bladder carcinoma stage T1 is an unpredictable disease that in some cases has a good prognosis with only local or no recurrence, but in others can appear as a more aggressive tumor with progression to ...

    Authors: Hans Olsson, Per Hultman, Johan Rosell, Peter Söderkvist and Staffan Jahnson

    Citation: BMC Urology 2013 13:5

    Published on:

  14. Content type: Review

    Prostate cancer is the second most commonly diagnosed cancer in American men over the age of 45 years and is the third most common cause of cancer related deaths in American men. In 2012 it is estimated that 2...

    Authors: Diego A Palacios, Makito Miyake and Charles J Rosser

    Citation: BMC Urology 2013 13:4

    Published on:

  15. Content type: Case report

    Papillary renal cell carcinoma is a rare cancer. Some cases can be attributed to individuals with hereditary renal cell carcinomas usually consisting of the clear cell subtype. In addition, two syndromes with ...

    Authors: Carl Ludwig Behnes, Christina Schlegel, Moneef Shoukier, Isabella Magiera, Frank Henschke, Alexander Schwarz, Felix Bremmer and Hagen Loertzer

    Citation: BMC Urology 2013 13:3

    Published on:

  16. Content type: Research article

    To clarify the significant clinicopathological and postdosimetric parameters to predict PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer.

    Authors: Nobumichi Tanaka, Isao Asakawa, Kiyohide Fujimoto, Satoshi Anai, Akihide Hirayama, Masatoshi Hasegawa, Noboru Konishi and Yoshihiko Hirao

    Citation: BMC Urology 2012 12:28

    Published on:

  17. Content type: Research article

    To assess the possibility of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) as a biological marker for detecting Bladder cancer (BCa), we examined the expression of HIP/PAP in bot...

    Authors: Yujiro Nitta, Hiroyuki Konishi, Tetsuya Makino, Tomoaki Tanaka, Hidenori Kawashima, Juan L Iovanna, Tatsuya Nakatani and Hiroshi Kiyama

    Citation: BMC Urology 2012 12:24

    Published on:

  18. Content type: Research article

    Prevention of bladder cancer recurrence is a central challenge in the management of this highly prevalent disease. The histone deacetylase inhibitor valproic acid (sodium valproate) has anti-angiogenic propert...

    Authors: Timothy K Byler, Dean Leocadio, Oleg Shapiro, Gennady Bratslavsky, Christopher J Stodgell, Ronald W Wood, Edward M Messing and Jay E Reeder

    Citation: BMC Urology 2012 12:21

    Published on: